JOE Cross-Journal Searching
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Journal of Endocrinology (2005) 186, 457-465    DOI: 10.1677/joe.1.06227
© 2005 Society for Endocrinology

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (25)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lappas, M.
Right arrow Articles by Rice, G. E
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lappas, M.
Right arrow Articles by Rice, G. E

Release and regulation of leptin, resistin and adiponectin from human placenta, fetal membranes, and maternal adipose tissue and skeletal muscle from normal and gestational diabetes mellitus-complicated pregnancies

Martha Lappas, Kirin Yee, Michael Permezel and Gregory E Rice

Department of Obstetrics and Gynaecology, University of Melbourne and Mercy Perinatal Research Centre, Mercy Hospital for Women, 126 Clarendon Street, East Melbourne, 3002 Victoria, Australia

(Requests for offprints should be addressed to M Lappas; Email: mlappas{at}unimelb.edu.au)

The aim of this study was to determine the release and regulation of leptin, resistin and adiponectin from human placenta and fetal membranes, and maternal subcutaneous adipose tissue and skeletal muscle obtained from normal and gestational diabetes mellitus (GDM)-complicated pregnancies at the time of Cesarean section. Tissue explants were incubated in the absence (basal control) or presence of 10 µg/ml lipopolysaccharide (LPS), 10, 20 or 40 ng/ml tumor necrosis factor-{alpha} (TNF-{alpha}), interleukin (IL)-6 and IL-8, 1 µM phorbol myristate acetate, 10, 20 and 40 mM glucose, 0.1, 1 and 10 µM insulin and 0.1 1 and 10 µM dexamethasone, progesterone and estrogen. After an 18-h incubation, the medium was collected and the release of leptin, resistin and adiponectin was quantified by ELISA. Human gestational tissues and maternal tissues released immunoreactive leptin, resistin and adiponectin; however, there was no difference in the release of either resistin or adiponectin between normal pregnant women and women with gestational diabetes. The release of leptin was significantly higher in placenta, amnion and choriodecidua obtained from normal pregnant women compared with women with GDM. However, in maternal tissues, the situation was reversed, with adipose tissue and skeletal muscle obtained from women with GDM releasing significantly greater amounts of leptin. In adipose tissue and skeletal muscle the release of leptin was significantly greater in insulin-controlled GDM compared with diet-controlled GDM, and leptin release from adipose tissue was significantly correlated with maternal body mass index. In all tissues tested, there was no effect of incubation with LPS, IL-6, IL-8 or TNF-{alpha} on leptin, resistin or adiponectin release. PMA significantly increased the release of resistin from placenta and adipose tissue. Insulin increased placental resistin release, whereas the hormones dexamethasone, progesterone and estrogen significantly decreased placental resistin release. The data presented in this study demonstrate that dysregulation of leptin metabolism and/or function in the placenta may be implicated in the pathogenesis of GDM. Furthermore, resistin release is greatly affected by a variety of inflammatory mediators and hormones.




This article has been cited by other articles:


Home page
Eur J EndocrinolHome page
A. Megia, J. Vendrell, C. Gutierrez, M. Sabate, M. Broch, J.-M. Fernandez-Real, and I. Simon
Insulin sensitivity and resistin levels in gestational diabetes mellitus and after parturition
Eur. J. Endocrinol., February 1, 2008; 158(2): 173 - 178.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
D. G. Haider, A. Handisurya, A. Storka, E. Vojtassakova, A. Luger, G. Pacini, A. Tura, M. Wolzt, and A. Kautzky-Willer
Visfatin Response to Glucose Is Reduced in Women With Gestational Diabetes Mellitus
Diabetes Care, July 1, 2007; 30(7): 1889 - 1891.
[Full Text] [PDF]


Home page
J. Lipid Res.Home page
A. L. Magnusson-Olsson, B. Hamark, A. Ericsson, M. Wennergren, T. Jansson, and T. L. Powell
Gestational and hormonal regulation of human placental lipoprotein lipase
J. Lipid Res., November 1, 2006; 47(11): 2551 - 2561.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
M. Weyermann, C. Beermann, H. Brenner, and D. Rothenbacher
Adiponectin and Leptin in Maternal Serum, Cord Blood, and Breast Milk
Clin. Chem., November 1, 2006; 52(11): 2095 - 2102.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
Y.-H. Chen, M.-J. Lee, H.-H. Chang, P.-F. Hung, and Y.-H. Kao
17{beta}-Estradiol Stimulates Resistin Gene Expression in 3T3-L1 Adipocytes via the Estrogen Receptor, Extracellularly Regulated Kinase, and CCAAT/Enhancer Binding Protein-{alpha} Pathways
Endocrinology, September 1, 2006; 147(9): 4496 - 4504.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
M. C. Henson and V. D. Castracane
Leptin in Pregnancy: An Update
Biol Reprod, February 1, 2006; 74(2): 218 - 229.
[Abstract] [Full Text] [PDF]




HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the Society for Endocrinology.